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The Road to Reality
G
aining new ground in scientific comprehension needs to radically overrule
current beliefs reversing constraints of popular science genre with a unique
combination of respect for the complexity of nature, the achievements of
the past, and striving toward the final goal to fight disease.
The coronary sinus, as minimally invasive access to the diseased heart, is an attrac-
tive route occupying generations of researchers. As in many other scientific develop-
ments and achievements in biology and medicine, coronary sinus interventions lack
uniformity and leave observers with plenty of uncertainty. Facts and myths are scat-
tered, leaving ground for speculations and piling up constraints for the future. These
constraints include the potential to recapitulate old mistakes or ill-fated avenues but
also leave room to bridge to new ideas on a sound basis of new understanding of
mistaken and unappreciated information.
The recent reports on the development of a coronary sinus reducer stent for the
treatment of chronic refractory angina pectoris have focused new interest on the con-
cept of coronary sinus interventions necessitating a second look at widely established
knowledge and a redirection of a potential ‘‘fausse route’’ jeopardizing scientific
targets. Permanent elevation of right-sided pressures in the heart is known to occur
during the development of cardiac failure. Our clinical predecessors knew that pa-
tients had a lucid interval with improvement of symptoms as soon as right atrial pres-
sure transmitted into the cardiac venous system, a phenomenon that is known also
from the Fontan circulation.1
Although this improvement does not last very long but rather deteriorates
promptly, it is certainly the basis for treatment options like the coronary reducer stent.
The Past and the Present of Coronary Sinus Interventions
The coronary sinus has been a surgical domain from its very beginning, culminating in
the methodology of retrograde cardioplegia as a powerful means to protect the heart
during global ischemia. Besides the current standard use of pacing electrodes for bi-
ventricular pacemakers or implantable cardioverter–defibrillators, various techniques
involving alterations of blood flow and pressure in coronary veins have been and still
are used in clinical practice and scientific research. Although some of them never
reached widespread clinical attention, the common goal of these methods is the
enhancement of retrograde perfusion to deprived myocardium, protection during
ischemia, and the prevention of reperfusion injury.
After the first clinical application of the Beck II procedure, a second ‘‘tidal wave’’
of interest arose at the beginning of the interventional era. However, most of the con-
cepts have been abandoned because of the lack of a plausible explanation of the
underlying mechanisms as well as the advancement of coronary artery interventions.2The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 5 1131
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stenting in acute coronary syndromes clearly shifted the inter-
est away from the coronary venous system. Despite consider-
able improvements in experimental and early clinical studies,
the existence of two schools of thought and the unilaterally
aligned interest of the medical device industry drowned an
otherwise interesting and clinically feasible concept for
almost three decades.3 Interestingly enough, the current
revival of interest is based on stem cell research, molecular
science, and the potential of regeneration on the one hand
and the clinical interest on advancement in interventional
technology on the other. The principles of the Beck II proce-
dure, which was assumed to be obsolete with the introduction
of coronary artery bypass grafting, gave many investigators
early knowledge on the principle of how to supply deprived
myocardium with oxygenated blood retroperfused in the
presence of coronary artery obstruction. According to Paz,4
this was also the motivation to develop the reducer stent (let-
ter to the editor). What was less appreciated is that there are
historic reports showing that new vessels are formed as a con-
sequence of the Beck II operation.2,5 One very important and
successful survivor of these techniques remains the applica-
tion of retrograde cardioplegia, which helped to protect the
myocardium even in an era of changing surgical demograph-
ics and dealing with more difficult and complex cases every
day.
Three decades ago the advances in catheter technology led
to the development of a more sophisticated method of syn-
chronizing retroperfusion (SRP) to diastole, allowing normal
drainage during systole aiming to penetrate the venous sys-
tem more effectively. The method was even evaluated as sup-
port of high-risk angioplasty6 and in patients with acute
coronary syndromes, but the concept had to be abandoned
due to the lack of efficiency and missed clinical end points.
A further advancement of the SRP concept was selective syn-
chronized suction and retroperfusion (SSR). SSR relies on
a selective access of the local coronary vein draining the is-
chemic area. In contrast to SRP, the regional cardiac veins
are emptied by suction of blood before retroinfusion.
The Role of Pressure Elevation in the Coronary Venous
Circulation
A different philosophy is the application of pressure-con-
trolled intermittent coronary sinus occlusion (PICSO).
PICSO works without additional retroinfusion of arterial
blood. The developed coronary sinus occlusion pressure is
a consequence of the squeezing action of the heart during sys-
tole and coronary venous flow. This allows a pressure wave
front to enter the ischemic coronary bed, redistributing blood
from normally perfused veins retrogradely into the microcir-
culation of deprived myocardium. After the systolic pressure
reaches a plateau, the vascular capacitance is completely
filled and the occlusion is released, allowing sufficient drain-
age. The significant difference compared with SRP and SSR1132 The Journal of Thoracic and Cardiovascular Surgery c Nois that the optimal occlusion time lasts over several heartbeats
and varies depending on myocardial function and myocardial
perfusion. The occlusion and release times are derived from
the coronary sinus pressure, which is measured through the
inner lumen of the dedicated balloon catheter. Early clinical
evaluations have shown benefits of PICSO during coronary
artery bypass grafting.7 and experimental studies demon-
strate the salvage potential for the ischemic myocardium.8
The Paradigm Change of Oxygen Delivery Toward
Endogenous Cardioprotection and Regeneration
Originally, all methods involving a retrograde myocardial
supply have been thought to act only by redistribution of
blood flow, especially emphasizing the oxygenated compo-
nent of the reperfusate. To reverse myocardial blood flow
totally results in normal cardiac action, at least in an empty
beating and vented heart, as can be observed during aortic
crossclamping and after the reversal of cardioplegic arrest
with warm blood. In regional ischemia, however, the imped-
ance of antegrade flow prevents effective nutritive backflow
of oxygenated blood, reversing venous flow toward under-
perfused areas.
Although experience should have led toward a different
school of thought, it is only recently that a clear picture of
coronary sinus interventions unfolds, bringing endogenous
molecular pathways into focus.
Relating Coronary Sinus Interventions and
Mechanotransduction
Recently, mechanotransduction and activation of venous
endothelium by pulsatile stretch of the elevated coronary ve-
nous pressure have been suggested to be the initial impulse
for the improvements observed with coronary sinus interven-
tions. The quantity of this mechanical stimulus is directly
related to the effectiveness of the method. In contrast to inter-
mittent occlusion techniques fully utilizing this principle, the
coronary sinus reducer stent causes a permanent but small
increase in the coronary venous pressure and results in dimin-
utive endothelial shear stress.
A permanent reduction of coronary sinus flow worsens
coronary perfusion, including reflexes such as bradycardia
and hypotension. The instance in which this was tolerated
in a number of patients having the Beck II procedure is based
on the reduced coronary inflow, the patchy microcirculatory
perfusion of the diseased heart, and in this respect Paz is right
in stating,’’ If we cannot increase the coronary arterial inflow
into deprived myocardium let’s limit the coronary venous
outflow.’’
As seen in several scientific evaluations of our own group,
optimizing the timing of venous pressure elevation defines
the shifted blood volumes and helps to control unwanted
side effects.9vember 2008
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Combining reports on the effects of mechanotransduction
with the hypothesis of the resurrection of inborn pathways
used during organogenesis for the repair of an adult failing
heart (embryonic recall) meets the claim of clinical signifi-
cance and a more consistent understanding of coronary sinus
interventions.10,11
The central contribution in this hypothesis is the discovery
of Zheng and associates,12 who demonstrated that coronary
microvascular endothelial cells under shear stress upregulate
vascular endothelial growth factor (VEGF). This mechanical
kinetic action of blood flow is also modeling the developing
heart.13
Pulsatile stretch on coronary venous endothelium by inter-
mittent elevated pressure resumes actions in the developing
heart and opens dormant pathways in the adult heart.
This ‘‘embryonic recall’’ might therefore enable revascu-
larization and structural regeneration, closing the cycle to the
histologic observations of the Beck II procedure and the
observations in PICSO experiments relating VEGF upregula-
tion and coronary venous pressure elevation.6 The same
relationship was found by Syeda and associates7 between
myocardial salvage and developed coronary sinus pressure
in experimental infarction in different species. In this case,
a high pressure is assumed to cause significant cyclic shear
stress and pulsatile stretch of the endothelium. VEGF and
other growth factors, such as the group of fibroblast growth
factors, are keys to angiogenesis and vasculogenesis. Grune-
wald and colleagues14 found that VEGF induces perivascular
expression of the chemokine SDF1, homing circulating pro-
genitor cells and enhancing in situ proliferation of resident
activated endothelial cells,14 thus promising that angiogene-
sis and regeneration can be achieved by mobilization, attrac-
tion, and implantation of pluripotent cells.
Vasodilatation of the myocardial vasculature is an impor-
tant target in preventing damage in deprived myocardial
zones. It appears to be essential in the salvage of ischemic
border zones and subsequently significant infarct size reduc-
tion. The similarity of myocardial salvage of all coronary si-
nus interventions, including retroperfusion of oxygenated
blood, underscores that vasodilatation and enhancement of
collateral flow, especially in border zones, is the pathophys-
iologic substrate in cardioprotection. Activation of obvious
pluripotent venous endothelium and the depending molecular
cascade may also play a hitherto unappreciated role in retro-
grade cardioplegia and warrants further studies.
Toward a New Understanding
Under the perspective mentioned earlier, a clear pattern un-
folds: with all coronary sinus interventions, a periodic pulsa-
tile stretch, activating venous endothelium, seems to be the
starting point of observed effects; the amplitude of the
pressure peaks in direct relation to optimal effectiveness.
The semantic differences in retroperfusion concepts versusThe Journal of Thoraintermittent occlusion are therefore irrelevant inasmuch as
the retroperfused blood cushion also periodically increases
venous outflow impedance followed by shear stress and pul-
satile stretch of endothelium during drainage in the coronary
venous system. Positive effects might have been obscured by
a limited amount of retroperfused volume and a less than
optimal pressure increase and therefore less than optimal
activation of venous endothelium. This inconsistency of ret-
roperfusion, however, seems to be solved by the optimized
action of PICSO.
Still, there is a great deal of ambivalence regarding the
wanted positive effects of high venous pressure on the activa-
tion of venous endothelium and the influences on coronary
perfusion, thus requiring an optimization as it is achieved
with PICSO scaling physiologic responses individually and
minimizing side effects.
Claiming clinical significance, we are now focusing on the
activation of venous endothelium embedding coronary sinus
interventions in the context of modern technology and the
background of the clinical imperative.
Beneficial effects can also be expected in prevention of re-
perfusion injury, still a major threat in cardiac surgery. Most
protective effects are associated with the release of nitric ox-
ide, which is activated in the presence of shear stress on the
endothelium. Therefore, it appears obvious to focus on ther-
apeutic methods that can generate this kind of mechanical
stress, such as PICSO, which provides an optimal activation
of venous endothelium through pulsatile stretch and shear
stress.
In Figure 1, the most important pathways resulting from
an activation of venous endothelium leading to cytoprotec-
tion, redistribution of flow and washout, and finally toward
myocardial salvage and regeneration are depicted.
A good example for the current paradigm change is also
retrograde cardioplegia. Routinely each day, in hundreds of
cardiac operations, we are using principles despite being
totally unaware of their potential help during surgery (ie,
vasodilatation of the coronary circulatory bed) and their
implications in structural regeneration. If applied correctly
and with optimal technology, we will gain another impor-
tant tool in current clinical practice. It is quite certain that
findings on the activation of coronary venous endothelium
will influence how and when we use retrograde cardiople-
gia. Mechanotransduction of the retrograde flowing perfus-
ate on venous endothelium and elevated pressure not only
should result in vasodilatation of the coronary bed but also
should change the pattern from reperfusion injury toward
regeneration.
The long-lasting history of coronary sinus interventions
showed a roller coaster–like wave form of research interest
and clinical focus. The current unmet clinical need in
myocardial regeneration eventually will bring these inter-
ventions back into the mainstream of interventional cardi-
ology and myocardial protection during cardiac surgery.cic and Cardiovascular Surgery c Volume 136, Number 5 1133
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sinus interventions to angiogenesis,
salvage, and cardioprotection. Mecha-
notransduction on the coronary vascu-
lature induces vasodilatation and
enhances angiogenesis in the ischemic
myocardium. Enhancement of collateral
flow in the border zone results in myo-
cardial salvage. Biomechanical inter-
vention of PICSO (since it resembles
the optimal intervention for mechano-
transduction) also potentially protects
from reperfusion injury by inducing
washout, thus protecting ischemic mi-
crocirculation. ATP, Adenosine triphos-
phate; VEGF, vascular endothelial
growth factor; NO, nitric oxide; NOS,
nitric oxide synthase; HO-1, heme oxy-
genase-1.Of special interest is the comparison between intra-aortic
balloon pumping and PICSO reported by Lazar and asso-
ciates,15 showing a synergistic effect of both methods on
salvage and reports on the clinical potential of PICSO dur-
ing myocardial infarction. The clinical potential of PICSO
also extends as adjunct therapy in acute myocardial infarc-
tion in revascularization procedures by limiting myocardial
necrosis and exceeding by far other clinically available
methods.10
Conclusions
Periodic and physiologically timed pressure elevation within
the coronary venous circulation, since it is based on the primary
benefactor, namely activation of venous endothelium, is the
legacy of coronary sinus interventions. To the best of our cur-
rent knowledge, the therapeutic range is determined by a pres-
sure control, taking into account the impedance changes within
the coronary circulation. With today’s existing technology, this
method may lead to a revival of our perception on current myo-
cardial protection via the coronary sinus in cardiosurgical as
well as in the interventional clinical arena.
Especially in our surgical discipline, activation of coro-
nary venous endothelium by periodic controlled elevation
of the coronary sinus pressure and inducing shear stress by1134 The Journal of Thoracic and Cardiovascular Surgery c Nomultiple doses of retrograde cardioplegia during global car-
diac arrest seem to be of advantage for the future of cardiac
surgery. Regenerative efforts in a quiescent organ are
supporting natural laws of recovery otherwise far beyond
any interventional domain.
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